R. Portales

Effect of tumour necrosis factor α blockade on bone metabolism in chronic inflammatory joint diseases

Jose L. Sanchez, F. Rey, R. Portales, 2016 .

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

A. Barton, M. Mayes, J. D. de Vries-Bouwstra, 2022, npj Genomic Medicine.

The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

T. Radstake, A. Herrick, R. Ríos-Fernandez, 2011, Genes and Immunity.

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

A. Fernández-Nebro, R. García-Vicuña, E. Tomero, 2005, The American journal of medicine.

Neurosarcoidosis: Analysis of a series of 20 patients

G. Martín, A. Conde, R. Portales, 2020, Medicina Clínica (English Edition).